HALOZYME THERAPEUTICS, INC. (HALO) Stock buybacks 2017–2025
HALOZYME THERAPEUTICS, INC. (HALO) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$342.4MFY2025 · since FY2017: $0 → $342.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $342.4M | +36.9% |
| FY2024 | $250.0M | -37.9% |
| FY2023 | $402.4M | +101.2% |
| FY2022 | $200.0M | -42.9% |
| FY2021 | $350.1M | +133.2% |
| FY2020 | $150.1M | -24.9% |
| FY2019 | $200.0M | — |
| FY2018 | $0 | — |
| FY2017 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More HALO financial trends
HALO RevenueHALO Net incomeHALO Net marginHALO Gross profitHALO Gross marginHALO Operating incomeHALO Operating marginHALO Operating cash flowHALO Free cash flowHALO Capital expendituresHALO Return on equityHALO Dividends paidHALO Total assetsHALO Total liabilitiesHALO Shareholders’ equityHALO overview →